Welcome to LookChem.com Sign In|Join Free

CAS

  • or

204452-94-8

Post Buying Request

204452-94-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

204452-94-8 Usage

Type of compound

Brominated derivative of 3-(2,2-diethoxy-ethoxy)benzene

Structure

Contains a bromine atom bonded to the benzene ring

Applications

Organic synthesis as a reagent or intermediate
Production of pharmaceuticals, agrochemicals, and materials
Building block in the synthesis of more complex organic compounds

Chemical industry use

Various applications as a building block for complex organic compounds

Handling and storage

Follow standard laboratory procedures for handling hazardous chemicals

Potential risks

Toxicity and environmental impact
These properties and contents are based on the information provided in the material and describe the chemical characteristics, applications, and handling requirements of 1-Bromo-3-(2,2-diethoxy-ethoxy)-benzene.

Check Digit Verification of cas no

The CAS Registry Mumber 204452-94-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,4,5 and 2 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 204452-94:
(8*2)+(7*0)+(6*4)+(5*4)+(4*5)+(3*2)+(2*9)+(1*4)=108
108 % 10 = 8
So 204452-94-8 is a valid CAS Registry Number.

204452-94-8Relevant articles and documents

Five-membered heterocyclic oxo carboxylic acid compound and medical application thereof

-

Paragraph 0707-0711, (2021/05/01)

The invention relates to a five-membered heterocyclic oxo carboxylic acid compound and a medical application thereof. Specifically, the invention relates to a compound, a pharmaceutical salt, a prodrug, a hydrate, a solvate or a crystal form as shown in a formula (I), and also relates to a preparation method of the compound, a pharmaceutical composition containing the compound and an application of the pharmaceutical composition as a secretion regulator of interferon type I, especially as an STING agonist in preparation of medicines for preventing and/or treating I-type interferon related diseases.

NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS

-

Paragraph 0258-0259, (2020/11/03)

Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Pyrimidone compound and application thereof

-

Paragraph 0275-0279, (2019/07/08)

The invention discloses a pyrimidone compound, pharmaceutically acceptable salt and solvate thereof, and provides a method for preparing the compounds, a composition containing the compounds and medicinal application of the compounds in preparation of medicines for treating diseases or disorders related to EED protein and/or PRC2 protein complex action mechanisms.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 204452-94-8
  • ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
  • [Hangzhou]86-571-87562588,87562561,87562573 Our Legal adviser: Lawyer